These included GNAS-AS1:TSS-DMR, ZIM2/PEG3/MIMT1, H19/MIR675, MEG3 and ZNF331:alt-TSS-DMR1, where more than 90% of the NB samples had unaltered methylation levels. This evidence concerns the gene MEG3 and neuroblastoma.